Our goal is to provide professional input and recommendations into Hungary's ongoing healthcare transformation, and improve the business and regulatory and operating environment for the life science industry.
Since its founding in 2020, the Healthcare Committee (upgraded from Working Group in 2022) has produced several policy materials and recommendations for the healthcare administration. Synthesizing input from AmCham’s pharmaceutical companies, medical device manufacturers, medical suppliers and medical service providers, the Committee published the Healthy Nation, Competitive Country recommendation packages by the following titles:
- Public Financing of Healthcare evaluates the current state and sustainability of the Healthcare financing system and various internal and external effects that impact it. It recommends a number of solutions to enhance supply security and more accessible procurement.
- Fast and Transparent Access to Health-giving Innovation discusses the role of Health innovation in the healthcare system, identifies breakout points and intervention options to both in the long and short-term.
- Models for the Synergy of Public and Private Healthcare details the benefits of having a collaborative public and private healthcare system, what is needed for companies to contribute more to the health of their employees, and how occupational medical exams may help screen early for health risks.
- In Improving the Institutional and Regulatory Environment for Clinical Trials we recommend several specific changes to existing regulation to quickly improve the institutional and regulatory environment for clinical trials, which would bring quick benefits to a high value-added sector.
In 2023 and 2024, committee members have had several high-level meetings with stakeholders in the Ministry of Interior, Ministry of Finance, Ministry for Technology and Industry, the National Directorate of Hospitals and others. We will continue to advocate for a sustainable, patient-centric and value-based healthcare, as we believe it is a key pillar of Hungary’s national competitiveness.
The Committee is led by Etelka Dobi, Patient Engagement and Government Affairs Lead, Janssen.
